An American investment bank has warned investors it will soon stop allowing the trading of marijuana companies operating in the US.

The Bank of New York Mellon (BNY Mellon) issued a notice to investors on Monday (September 30), announcing that it will not allow incoming positions or trading of cannabis stocks participating in the US market starting on November 30.


This new mandate only applies to companies with marijuana assets in the US. The bank explained that Canadian companies without any American “operations or distribution” don’t violate the federal Controlled Substances Act.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The bank said moving forward it will consider reviews on positions that “were subject of an order, transaction or incoming transfer to ensure compliance due to federal laws and regulations.”

BNY Mellon indicated that the ban on trading for these stocks is related to the federal illegality of the drug in the US. Cannabis is still a Schedule I drug in the eyes of the federal government, despite the legalization programs seen at the state level.

So far, 11 states and the District of Columbia have legalized marijuana, both for medical and recreational use. Additionally, 22 other states have legalized medical cannabis products.

“BNY Mellon continues to monitor trends in CRB (cannabis-related business) transactions and may impose additional restrictions or require additional information in the future,” the bank said in its note.

The bank asked investors to hold off on trading or transferring these now disallowed securities. BNY Mellon stated in its warning:

During this time period, up until November 30, the effective date, we encourage you to not trade or transfer in any non-permitted CRB securities and BNY Mellon’s Pershing reserves the right to reject any non-permitted CRB trades or deposits. After November 30, BNY Mellon’s Pershing will no longer accept any non-permitted CRB trades or deposits.

In September, the US cannabis industry received a vote of confidence when the House of Representatives approved the Secure and Fair Enforcement Banking Act of 2019, otherwise known as the SAFE Banking Act.

This bill seeks to create protections for banks and other financial institutions willing to offer banking services to cannabis and hemp companies in the US.

The SAFE Banking Act is now en route to the Senate, were it will most likely face an uphill climb to be approved, according to experts.

“The industry is hanging onto the hope that this would make it a lot easier for a lot of these bigger plays to grow a lot quicker, capture market share and bring over the black market to legal channels,” Nawan Butt, associate portfolio manager Purpose Investments, previously told the Investing News Network.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, in connection with the previously announced share consolidation on a thirty (30) for one (1) basis (the “Consolidation”), the Company will be changing its name to West Island Brands Inc. (the “Name Change”).

The common shares are scheduled to begin trading on a post-consolidation basis at market open on October 20, 2021 under the stock symbol “WIB”. The new CUSIP number will be 953400108 and the new ISIN number will be CA9534001081. Following the Consolidation, the Company will have approximately 10,712,484 common shares issued and outstanding.

Keep reading... Show less

In the cannabis space this week, a popular beverage maker hired a new executive in hopes of pursuing opportunities in the cannabis drink industry.

Meanwhile, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced a fresh acquisition agreement for a partner designed to boost its presence in a potentially available US adult-use cannabis market.

Keep reading... Show less

Via InvestorWireIBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be collaborating with Microdose Psychedelic Insights for the Psych e delic Capital: October 2021 Conference which is set to be held in an entirely virtual format on Oct. 28, 2021.

The Psychedelic Capital: October Conference is set to be a virtual event, covering the most innovative and cutting-edge companies, latest IPOs, newest opportunities and deepest insights into the global psychedelic industry. From exploring ongoing governmental policy shifts to commercial product breakthroughs, the conference will serve to educate attendees on the potential uses and benefits attached to psychedelics in today’s environment.

Keep reading... Show less

 Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”) today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers License application.

Record September Shipments
Adastra shipped 68,272 consumer-packaged units and 20,000g of bulk extract in September compared to 41,571 units in September 2020 , a 64% increase year over year.

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that, pursuant to a director’s resolution, the Company will be consolidating its issued and outstanding share capital on the basis of every thirty (30) old Common Shares being consolidated into one (1) new Common Share (the “Share Consolidation”). Any fractional shares remaining after giving effect to the Share Consolidation will be cancelled.

As a result, the outstanding Common Shares of the Company will be reduced to approximately 10,712,484. The Company has no other securities outstanding.

Keep reading... Show less